SCHEMBL25838145

SCHEMBL25838145

O=Nc1ccc(C(=O)O)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
PDE4A P27815 1/20 0.41
BLVRB P30043 1/20 0.41
KDR P35968 1/20 0.41
HTT P42858 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ASPH Q12797 2/20 0.40
KDM8 Q8N371 2/20 0.40
RARB P10826 3/20 0.40
RARA P10276 2/20 0.40
RARG P13631 1/20 0.40
CYP1A2 P05177 1/20 0.39
SELL P14151 1/20 0.38
SELP P16109 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061851 0.84 SIRT5 (0.48) ALBMEN1KMT2APDE4ABLVRB
SCHEMBL25838160 0.82 MAOB (0.43) MEN1KMT2ACES2CES1KDM4E
SCHEMBL7202105 0.81 MEN1 (0.50) MEN1KMT2APDE4ABLVRBKDR
SCHEMBL15391204 0.78 HSD17B10 (0.41) ALBMEN1KMT2APDE4ABLVRB
SCHEMBL27202235 0.78 TP53 (0.40) ALBMEN1KMT2APDE4ABLVRB
SCHEMBL8899172 0.78 MEN1 (0.42) MEN1KMT2APDE4ABLVRBKDR
SCHEMBL28210229 0.77 CES2 (0.46) MEN1KMT2APDE4ABLVRBKDR
SCHEMBL12059195 0.76 ALDH1A1 (0.50) MEN1KMT2APDE4ABLVRBKDR
SCHEMBL12589872 0.76 RXRB (0.45) MEN1KMT2APDE4ABLVRBKDR
SCHEMBL12694619 0.74 CYP1A2 (0.37) MEN1KMT2AHTTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226228-A1 POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226228-A1 POSITRON IMAGING TOMOGRAPHY IMAGING AGENT COMPOSITION AND METHOD FOR DETECTION OF BACTERIAL INFECTION TLR5, SLC10A2, FNTB ALB 2837/4885MEN1 1185/4885KMT2A 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.